FierceBiotech  Feb 15  Comment 
Versant’s Jecure Therapeutics debuts with a focus on NASH, fibrosis badams Wed, 02/15/2017 - 08:39
FierceBiotech  Jan 3  Comment 
Versant closes $400M life sciences fund as it hits 2017 running badams Tue, 01/03/2017 - 08:57
FierceBiotech  Dec 19  Comment 
Northern Biologics merges with Mosaic Bio as Versant, Celgene boost involvement badams Mon, 12/19/2016 - 04:00
GenEng News  Dec 12  Comment 
Stem-cell therapy firm BlueRock Therapeutics has launched with the backing of a combined $225 million Series A investment by Bayer and healthcare investment firm Versant Ventures. BlueRock’s initial programs will focus on induced pluripotent...
Reuters  Dec 12  Comment 
* Focus on cardiovascular, neurodegenerative conditions (Adds comments from Bayer/Versant executives)
FierceBiotech  Dec 12  Comment 
Bayer, Versant join forces on $225M Series A for stem cell upstart badams Mon, 12/12/2016 - 07:26
Wall Street Journal  Dec 9  Comment 
Bayer and U.S. healthcare investor Versant Ventures plan to establish a stem-cell research company called BlueRock Therapeutics, with initial joint funding of $225 million.
FierceBiotech  Oct 28  Comment 
Versant Ventures has come up with an $11.3 million Series A round for Turnstone Biologics, an Ontario-based biotech that is taking an oncolytics platform technology developed by a trio of Canadian scientists and ramping up a new program aimed at...
FierceBiotech  Oct 1  Comment 
OrbiMed has joined with New Enterprise Associates and Versant Ventures to funnel $35 million (€31 million) into a French startup that is developing a treatment for a common form of dwarfism. The sizable Series A round will support the advance...



Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki